BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30389454)

  • 1. Colorimetric detection of PCA3 in urine for prostate cancer diagnosis using thiol-labeled PCR primer and unmodified gold nanoparticles.
    Htoo KPP; Yamkamon V; Yainoy S; Suksrichavalit T; Viseshsindh W; Eiamphungporn W
    Clin Chim Acta; 2019 Jan; 488():40-49. PubMed ID: 30389454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct colorimetric diagnosis of pathogen infections by utilizing thiol-labeled PCR primers and unmodified gold nanoparticles.
    Jung YL; Jung C; Parab H; Li T; Park HG
    Biosens Bioelectron; 2010 Apr; 25(8):1941-6. PubMed ID: 20138499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence‑specific RNA capture.
    Zheng K; Dou Y; He L; Li H; Zhang Z; Chen Y; Ye A; Liu W; Kong L
    Oncol Rep; 2015 Nov; 34(5):2439-44. PubMed ID: 26351770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
    Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
    Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
    Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
    Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
    Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
    Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time colorimetric detection of DNA methylation of the
    Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
    Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary
    Yamkamon V; Htoo KPP; Yainoy S; Suksrichavalit T; Tangchaikeeree T; Eiamphungporn W
    EXCLI J; 2020; 19():501-513. PubMed ID: 32398974
    [No Abstract]   [Full Text] [Related]  

  • 9. "Mix-to-Go" Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction.
    Wang J; Koo KM; Wang Y; Trau M
    Anal Chem; 2018 Nov; 90(21):12698-12705. PubMed ID: 30260630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection.
    Foj L; Milà M; Mengual L; Luque P; Alcaraz A; Jiménez W; Filella X
    Clin Chim Acta; 2014 Aug; 435():53-8. PubMed ID: 24803095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmodified gold nanoparticles as a simple colorimetric probe for ramoplanin detection.
    Teepoo S; Chumsaeng P; Palasak K; Bousod N; Mhadbamrung N; Sae-lim P
    Talanta; 2013 Dec; 117():518-22. PubMed ID: 24209375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis.
    Neves AF; Dias-Oliveira JD; Araújo TG; Marangoni K; Goulart LR
    Clin Chem Lab Med; 2013 Apr; 51(4):881-7. PubMed ID: 23241599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progensa™ PCA3 test for prostate cancer.
    Durand X; Moutereau S; Xylinas E; de la Taille A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):137-44. PubMed ID: 21405964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative real-time RT-PCR assay for PCA3.
    Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
    Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular PCA3 diagnostics on prostatic fluid.
    van Gils MP; Cornel EB; Hessels D; Peelen WP; Witjes JA; Mulders PF; Rittenhouse HG; Schalken JA
    Prostate; 2007 Jun; 67(8):881-7. PubMed ID: 17440939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of extremely stable dual functionalized gold nanoparticles for effective colorimetric detection of clenbuterol and ractopamine in human urine samples.
    Simon T; Shellaiah M; Steffi P; Sun KW; Ko FH
    Anal Chim Acta; 2018 Sep; 1023():96-104. PubMed ID: 29754612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorimetric theophylline aggregation assay using an RNA aptamer and non-crosslinking gold nanoparticles.
    Ma X; Guo Z; Mao Z; Tang Y; Miao P
    Mikrochim Acta; 2017 Dec; 185(1):33. PubMed ID: 29594625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorimetric detection of low dose gamma radiation based on the aggregation of gold nanoparticles and its application for the blood irradiation.
    Song Y; Feng D; Shao S; Liang J
    Talanta; 2018 Sep; 187():308-313. PubMed ID: 29853052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodiamonds conjugated to gold nanoparticles for colorimetric detection of clenbuterol and chromium(III) in urine.
    Shellaiah M; Simon T; Venkatesan P; Sun KW; Ko FH; Wu SP
    Mikrochim Acta; 2017 Dec; 185(1):74. PubMed ID: 29594526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals.
    Moradi Sardareh H; Goodarzi MT; Yadegar-Azari R; Poorolajal J; Mousavi-Bahar SH; Saidijam M
    Urol J; 2014 Nov; 11(6):1952-8. PubMed ID: 25433473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.